Presentation TCT 2012 Twelve-Month Clinical Efficacy and Safety of Zotarolimus- versus Everolimus-Eluting Stents in a Series of Asian Population Presenter: SunWon Kim January 03, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB Presentation TCT 2012 Up Next Presentation TCT 2012 Gradual Reduction in the age Adjusted Nationwide Trends in the Incidence of Cardiogenic Shock Occurring in the setting of ST Elevation Myocardial Infarction Across Different... Presenter: Mohammad Reza Movahed January 03, 2012 More slides + Presentation TCT 2012 DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious. Presenter: John Ormiston January 03, 2012 Presentation TCT 2012 First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial Presenter: Mengyue Yu January 03, 2012 We Recommend
Presentation TCT 2012 Gradual Reduction in the age Adjusted Nationwide Trends in the Incidence of Cardiogenic Shock Occurring in the setting of ST Elevation Myocardial Infarction Across Different... Presenter: Mohammad Reza Movahed January 03, 2012
Presentation TCT 2012 DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious. Presenter: John Ormiston January 03, 2012
Presentation TCT 2012 First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial Presenter: Mengyue Yu January 03, 2012